Navigation Links
ValGenesis Inc. Successfully Completes Service Organization Controls 2 (SOC 2) Report under AT Section 101

FREMONT, Calif., April 1, 2015 /PRNewswire/ -- ValGenesis Inc., the market leader in enterprise Validation Lifecycle Management Software solutions, announced today that it has completed its Service Organization Controls 2 (SOC 2) examination under AT Section 101, Attest Engagements (AICPA, Professional Standards) for the period of January 1st  2014  through December 31st 2014. 

Logo -

The SOC 2 examination is performed in accordance with AT Section 101, Attest Engagements (AICPA, Professional Standards) with completion denoting that selected ValGenesis Inc. processes, procedures and controls have been formally evaluated and tested by an independent accounting and auditing firm.  The examination included the company's controls related to the Trust Services Principles and Criteria of Security, Availability, Processing, Integrity and Confidentiality. Further, the SOC 2 is designated as an acceptable method for user entity management thereby obtaining assurance of service organization internal controls over Security, Availability, Processing Integrity and Confidentiality without conducting additional assessments. 

As a widely recognized exam, the SOC 2 examination indicates that a service organization has been through an evaluation of their control activities as they relate to the applicable Trust Services Principles and Criteria. A Type II report not only includes the service organization's system description, but also includes detailed testing of the design and operating effectiveness of the service organization's controls.

Through its validated private cloud, hosted ValGenesis Validation Lifecycle Management System (VLMS), allows companies of any size to manage their Validation Lifecycle, Risk and Change management processes as a 100% paperless process with built-in best practices. Organizations with certification and compliance requirements such as FDA, EMA and HIPAA etc., may request and leverage the ValGenesis SOC 2 Type 2 audit report as part of their compliance strategy.

Quote From ValGenesis

"With our successful completion of SOC 2 Type 2 audit, we are able to provide our customers with greater insights into our controls, procedures and systems involving our hosting solution," stated Siva Samy, Chief Product Strategist, ValGenesis, Inc. "Regulated life science companies continue to choose ValGenesis primarily because we embrace the changing regulatory and compliance landscape. Our ability to successfully pass this rigorous, in-depth audit confirms that ValGenesis has the proper controls and processes in place thus delivering the highest-quality validated hosting services to our clients."

Quote From A-lign

"ValGenesis' leadership and IT teams demonstrate an exceptional commitment to transparency, proactively implementing controls and protocols for security, availability, processing, integrity and confidentiality through the audit of ValGenesis VLMS," stated Scott Price, Managing Partner at A-lign. "It has been our pleasure to work with a company determined to follow the approved processes and procedures, a company that has truly achieved best practices with their cloud solution."

About ValGenesis
ValGenesis, Inc. is the creator of an innovative software platform serving as the foundation for managing compliance-based validation activities in Life Sciences companies. ValGenesis, Inc. provides the first enterprise application to manage the corporate validation lifecycle process. As the only system for managing validation execution and approval 100% electronically, ValGenesis was selected by an industry peer review committee to receive the Parenteral Drug Association (PDA) New Innovative Technology Award. The solution is fully compliant with U.S. FDA 21 CFR Part 11 and Annex 11 requirements. For more information, visit

Media Contact:

Mike Beaudro, Marketing Manager 
ValGenesis, Inc. | 42840 Christy St. | Fremont, CA 94538 
Ph: 510 445 0505 | Email

SOURCE ValGenesis
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. University of Maryland Researchers Successfully Produce Genome-edited Pigs Using Revolutionary Technology
2. Penn researchers successfully alleviate pulmonary inflammation with targeted drug delivery
3. Proove Biosciences Successfully Presents Data and Exhibits at the Eastern Pain Association’s Annual Meeting in New York, New York
4. Scientists develop way to successfully give nanoparticle therapeutics orally
5. VIVEX BIOMEDICAL Successfully Completes $7.6 Million Round of Financing
6. Ironridge Global Partners, LLC Successfully Concludes Equity Financings of ULURU Inc.
7. Biotrial Bioanalytical Services (BBS) Proves Top-Quality Performance by Successfully Passing Another FDA Inspection
8. Unique Extracellular Matrix Used in Patient Successfully Treated for Flesh Eating Bacteria
9. Cobalt Technologies Successfully Scales Commercial n-Butanol Production
10. Cryos International Completes Groundbreaking Sperm Migration to Orlando, Florida
11. SurePure Completes Verification and Approved for Trading on the OTCQB Marketplace
Post Your Comments:
(Date:8/14/2019)... ... August 13, 2019 , ... INDIGO Biosciences, Inc. ... solutions, announced the appointment of Mark McLoughlin to the Company’s Board of Directors. ... McLoughlin will lend his healthcare expertise and extensive background in laboratory and scientific ...
(Date:8/7/2019)... ... ... Locus Agricultural Solutions (Locus AG) reports record levels of carbon sequestered in ... ® , which is pulling up to 121% more carbon into the soil than ... from the treatment of almonds, cherries, turf/sod, grapes and citrus across the U.S., as ...
(Date:8/6/2019)... ... August 05, 2019 , ... Advanced Clinical, a ... a distinguished leader by PharmaVOICE magazine, earning him a prestigious spot on the ... July/August special issue. , As the executive vice president of business development and ...
(Date:7/30/2019)... ... July 30, 2019 , ... The summer ... cooking events company. Not only has the company already hosted many of its ... Cooking Parties to its guests. , With Lajollacooks4u’s Private Cooking Parties, guests prepare ...
Breaking Biology Technology:
(Date:8/15/2019)... ... , ... Deep Science Ventures (DSV), a new paradigm for applied ... dedicated to building 100 companies over the next 10 years to address the urgent ... Deep Science Ventures was founded to create a better method for launching science companies; ...
(Date:8/14/2019)... ... ... Join Jonathan Riek, PhD, VP, Musculoskeletal & Metabolic Imaging, BioTel Research in ... learn about two common imaging methods in NAFLD/NASH to aid with early disease diagnosis, ... disease, with a worldwide prevalence of 20-46 percent. NAFLD can be subdivided into simple ...
(Date:8/9/2019)... ... August 09, 2019 , ... With a demand in ... and more patients will visit urgent care centers (UCC) in the coming years, according ... report, The Market for Urgent Care Centers , is a detailed look at ...
Breaking Biology News(10 mins):